Business

Cannabis companies are using a loophole in Colorado’s strict limits on marijuana advertising by sponsoring state highways and putting their names on roadside signs.

Last year was supposed to be when the cannabis industry demonstrated to Wall Street that it was deserving of its lofty premium and could become profitable on a recurring basis. Of course, hindsight being what it is, we know that didn't happen. Instead, marijuana stocks actually logged their worst year to date.

The week ended on a high note for Canopy Growth (CGC).

When it comes to pot prohibition, it's state legislatures that refuse to act who are out of step with the times.

Last year wasn't a great one for advancing marijuana legalization at the state level. Despite high hopes for New Jersey and New York, state legislatures in Trenton and Albany couldn't quite get their acts together, and promising efforts petered out. Illinois was the only state to approve marijuana legalization in 2019.

Washington House lawmakers Sunday passed a bill intended to address racial inequity within the cannabis industry by issuing previously forfeited, canceled and revoked retail licenses to applicants of a new social equity program.

President Trump proposed a budget that will end the existing protection policy for state medical marijuana programs. Yesterday, in Trump Denies Protection to State Medical Marijuana Programs, I discussed how President Trump wants to ignore Congress’s introduced policy to protect the states that have legalized marijuana from federal interference. However, Congress decided to fight back against President Trump.

Canopy Growth posts a quarterly loss narrower than expected.

Shares of Canopy Growth (CGC) - Get Report jumped  20% Friday to $23.70 after the Canadian cannabis company reported a narrower-than-expected fiscal third-quarter loss as revenue topped analysts' estimates.

The startup-laden cannabis industry is probably just right for those who are willing to forego a few extra dollars on their paychecks for the possibility of a bigger payout later when the company grows or goes public.

Giving employees an equity stake is far from an uncommon practice in startups, and companies in turn may see it as a way to save money on payroll and encourage workers to do more.

Ownership interests in the often heavily regulated cannabis industry, however, typically come with regulatory implications by necessity.

State lawmakers took steps on two bills Thursday that could bring protections for companies that insure cannabis-related companies in the Garden State and also allow those on workers’ compensation to have their medical weed covered.

The state Assembly committee on financial institutions advanced the two bills, but the state Senate has yet to take up either.

The U.S. is expected to lead the world in cannabis sales, and these are the states you'll want to monitor the closest.

Despite its recent hiccups, marijuana is expected to be one of the fastest-growing industries on the planet over the next decade. Although estimates rightly vary on Wall Street, which is to be expected of an industry with no modern-day legal precedent, the expectation is that global pot sales could hit $50 billion, at minimum, by 2030. For context, the green rush brought in $10.9 billion worldwide in 2018.